Specialty Pharmacy

Patients administered PRO 140 monotherapy reach 2 years of complete remission in trial.

Obesity management in women is vital to reduce the risk of cancer.

Gene therapy may protect against rare neurodegenerative disorder.

Hormone receptor testing may be unnecessary in breast cancer patients.

US National Institutes of Health grant will link universities studying Alzheimer’s disease and related dementia.

Stem cell medical tourism increasingly takes advantage of patients with debilitating conditions.

Top news of the day from across the healthcare landscape.

Marc O'Connor, chief operating officer of Curant Health, discusses how the Affordable Care Act has impacted specialty pharmacy stakeholders.

The Specialty Pharmacy Podcast Show will cover the vast business topics about the complex business of the specialty pharmacy sector of the pharmacy industry.

Patients with septic perianal Crohn’s disease have infected abscesses that are difficult to treat.

Study targets how HIV avoids immune system defenses.

Mechanism behind novel BRAF inhibitor resistance among patients with melanoma discovered.

Top news of the day from across the health care landscape.

Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers carry similar outcomes in study.

Aromatase inhibitors in human estrogen-receptor positive breast cancer can cause tumor mutations.

A 4-dimensional lung scanning platform may advance patient care.

Patients taking medication that inhibits IL-1beta are 300 times more likely to develop a flesh-eating infection.

Research identifies which melanoma patients will respond to immunotherapy drugs.

The lack of rigid fatigue descriptions in multiple sclerosis inhibit treatment advances.

Obesity becoming a growing health concern for cancer survivors, specifically breast and colorectal cancers.

Top news of the day from across the health care landscape.

Brain training exercise may help treat patients with conditions such as dementia.

Protein inhibition shows promising reducing lung cancer progression.

Researchers seek to develop drugs that block the Nef protein that is associated with HIV progressing to AIDS.

Patient satisfaction and coordination of care are vital to the success of a high cost specialty drug regimen.

Study will be the first to evaluate the role of metformin on liver fibrosis in HCV-HIV co-infected and HCV mono-infected patients.

Drug resistance not found to increase among patients with HIV.

Sedentary behavior can lead to cardiovascular disease, and in turn, diabetic retinopathy.